Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
Year of publication: |
2013
|
---|---|
Authors: | Sanchez-de la Rosa, Rainel ; Sabater, Eliazar ; Casado, Miguel A. |
Published in: |
Health economics review. - Heidelberg : Springer, ISSN 2191-1991, ZDB-ID 2634483-X. - Vol. 3.2013, 13, p. 1-5
|
Subject: | relapsing-remitting multiple sclerosis (RRMS) | cost analysis model | economic evaluation | glatiramer acetate | fingolimod | Chronische Krankheit | Chronic disease | Arzneimittel | Pharmaceuticals | Kosten-Nutzen-Analyse | Cost-benefit analysis | Spanien | Spain |
Extent: | graph. Darst. |
---|---|
Type of publication: | Article |
Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
Language: | English |
Notes: | Systemvoraussetzung Acrobat Reader |
Other identifiers: | 10.1186/2191-1991-3-13 [DOI] hdl:10419/77837 [Handle] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Sanchez-de la Rosa, Rainel, (2013)
-
Rosa, Rainel Sanchez-de la, (2013)
-
Zapotoczky, Klaus, (1999)
- More ...
-
Sanchez-de la Rosa, Rainel, (2013)
-
Sanchez-de la Rosa, Rainel, (2013)
-
Budgetary impact analysis of buprenorphinenaloxone combination (Suboxone®) in Spain
Martinez-Raga, Jose, (2012)
- More ...